List view / Grid view

Mike Ward (Clarivate)

 

article

Exploring the potential of ADCs beyond oncology

Antibody Drug Conjugates (ADCs) are already deployed as part of…

6 August 2024 | By

Antibody Drug Conjugates (ADCs) are already deployed as part of the roster of oncology treatments, but here, Mike Ward, Head of Thought Leadership for Life Sciences & Healthcare, Clarivate, looks into their potential to help treat a whole range of other diseases and conditions. He discusses the barriers and enablers…